Robert Alexander Ingram is a director of Biocryst Pharmaceuticals Inc.
Person profile
Roles
Address
Durham, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BIOCRYST PHARMACEUTICALS INC
2 Mar 23
4
Black Diamond Therapeutics, Inc.
19 Dec 22
4
BIOCRYST PHARMACEUTICALS INC
2 Dec 22
4
Black Diamond Therapeutics, Inc.
19 Sep 22
4
BIOCRYST PHARMACEUTICALS INC
2 Sep 22
4
Black Diamond Therapeutics, Inc.
17 Jun 22
4
Black Diamond Therapeutics, Inc.
13 Jun 22
4
BIOCRYST PHARMACEUTICALS INC
9 Jun 22
4
BIOCRYST PHARMACEUTICALS INC
2 Jun 22
4
Black Diamond Therapeutics, Inc.
18 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 23 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 8.85 | 2,259 | 19.99 k | 100,198 |
16 Dec 22 | BDTX Black Diamond Therapeutics | Common Stock | Grant | Acquire A | No | No | 1.5 | 9,375 | 14.06 k | 42,854 |
30 Nov 22 | BCRX Biocryst Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 13.36 | 1,497 | 20.00 k | 97,939 |